225 related articles for article (PubMed ID: 19741567)
1. Selective serotonin reuptake inhibitors pathway.
Sangkuhl K; Klein TE; Altman RB
Pharmacogenet Genomics; 2009 Nov; 19(11):907-9. PubMed ID: 19741567
[No Abstract] [Full Text] [Related]
2. Studies towards the next generation of antidepressants. Part 1: Indolylcyclohexylamines as potent serotonin reuptake inhibitors.
Meagher KL; Mewshaw RE; Evrard DA; Zhou P; Smith DL; Scerni R; Spangler T; Abulhawa S; Shi X; Schechter LE; Andree TH
Bioorg Med Chem Lett; 2001 Jul; 11(14):1885-8. PubMed ID: 11459653
[TBL] [Abstract][Full Text] [Related]
3. Clinical implication of microdialysis findings.
Deakin JF; Graeff FG; Guimaraes FS
Trends Pharmacol Sci; 1993 Jul; 14(7):263. PubMed ID: 8129813
[No Abstract] [Full Text] [Related]
4. Depression and serotonin: a never ending story.
Marazziti D
Curr Drug Targets; 2013 May; 14(5):513. PubMed ID: 23547753
[No Abstract] [Full Text] [Related]
5. 5-HT and antidepressants: in vitro and in vivo release studies.
Briley M; Moret C
Trends Pharmacol Sci; 1993 Nov; 14(11):396-7. PubMed ID: 8296396
[No Abstract] [Full Text] [Related]
6. Understanding the molecular pharmacology of the serotonergic system: using fluoxetine as a model.
Sghendo L; Mifsud J
J Pharm Pharmacol; 2012 Mar; 64(3):317-25. PubMed ID: 22309263
[TBL] [Abstract][Full Text] [Related]
7. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
[TBL] [Abstract][Full Text] [Related]
8. Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.
Andrews M; Brown A; Chiva JY; Fradet D; Gordon D; Lansdell M; MacKenny M
Bioorg Med Chem Lett; 2009 Oct; 19(20):5893-7. PubMed ID: 19740658
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters.
Andersen J; Kristensen AS; Bang-Andersen B; Strømgaard K
Chem Commun (Camb); 2009 Jul; (25):3677-92. PubMed ID: 19557250
[TBL] [Abstract][Full Text] [Related]
10. The serotonin transporter messenger RNA level in rat brain is not regulated by antidepressants.
Koed K; Linnet K
Biol Psychiatry; 1997 Dec; 42(12):1177-80. PubMed ID: 9426888
[No Abstract] [Full Text] [Related]
11. New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants.
Martínez J; Pérez S; Oficialdegui AM; Heras B; Orús L; Villanueva H; Palop JA; Roca J; Mourelle M; Bosch A; Del Castillo JC; Lasheras B; Tordera R; del Río J; Monge A
Eur J Med Chem; 2001 Jan; 36(1):55-61. PubMed ID: 11231049
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and systematic evaluation of 4-arylpiperazine- and 4-benzylpiperidine napthyl ethers as inhibitors of monoamine neurotransmitters reuptake.
Paudel S; Min X; Acharya S; Khadka DB; Yoon G; Kim KM; Cheon SH
Bioorg Med Chem; 2018 Nov; 26(20):5538-5546. PubMed ID: 30293797
[TBL] [Abstract][Full Text] [Related]
13. [The influence of genetic variations on the effect of selective serotonin reuptake inhibitors].
Bukh JO; Bock C; Mors NP; Kessing LV
Ugeskr Laeger; 2007 Apr; 169(16):1439-41. PubMed ID: 17484840
[TBL] [Abstract][Full Text] [Related]
14. Subtherapeutic doses of SSRI antidepressants demonstrate considerable serotonin transporter occupancy: implications for tapering SSRIs.
Shapiro BB
Psychopharmacology (Berl); 2018 Sep; 235(9):2779-2781. PubMed ID: 30097698
[No Abstract] [Full Text] [Related]
15. Serotonin: current understanding and the way forward.
Dinan TG
Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():19-21. PubMed ID: 8732440
[TBL] [Abstract][Full Text] [Related]
16. The effects of antidepressant treatment on serotonergic and dopaminergic systems in Fawn-Hooded rats: a quantitative autoradiography study.
Chen F; Lawrence AJ
Brain Res; 2003 Jun; 976(1):22-9. PubMed ID: 12763618
[TBL] [Abstract][Full Text] [Related]
17. A mouse model to address unresolved antidepressant issues.
Homberg JR
Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3463-4. PubMed ID: 21368215
[No Abstract] [Full Text] [Related]
18. 3 Beta-(4-ethyl-3-iodophenyl)nortropane-2 beta-carboxylic acid methyl ester as a high-affinity selective ligand for the serotonin transporter.
Blough BE; Abraham P; Mills AC; Lewin AH; Boja JW; Scheffel U; Kuhar MJ; Carroll FI
J Med Chem; 1997 Nov; 40(24):3861-4. PubMed ID: 9397165
[No Abstract] [Full Text] [Related]
19. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
Sánchez C; Hyttel J
Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
[TBL] [Abstract][Full Text] [Related]
20. 5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressants.
Matzen L; van Amsterdam C; Rautenberg W; Greiner HE; Harting J; Seyfried CA; Böttcher H
J Med Chem; 2000 Mar; 43(6):1149-57. PubMed ID: 10737747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
